close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis  

What's this?
Dollar7702Point02
Implied share price

Buy Undervalued by 42056.7%

5% margin of safety What's this?

EV / Revenue
Use Average
PLX
Protalix BioTherapeutics Inc.
KUN
China Shenghuo Pharmaceutical Hldg, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
SNY
Sanofi SA (ADR)
Change
AMGN
Amgen, Inc.
Change
20921.08 48.12 27840.41 14.62 2.05 7.19
All amounts in millions
from last financial year
         
Implied Share Price $7702.02 $46945.24 $155334.08 $527584.49 $513638.53
Market Cap 1,701 1,229,412 159,224 126,048 121,501
Net Debt -52 20 4,504 6,333 12,727
Enterprise Value (EV) 1,656 1,229,432 163,728 68,248 134,228
Revenue 34 44 11,201 33,306 18,676
Balance Sheet          
Total Assets 78 58 22,496 96,055 66,125
Total Liabilities 82 56 11,127 39,151 44,029
Shareholders Equity -3 2 11,369 56,904 22,096.0

Where are the EBIT and EBITDA figures?

Certain companies and those in specific industries (for example insurance) do not report financial results at the EBIT or EBITDA line. For these companies where Valuecruncher does not have EBIT or EBITDA numbers we exclude the valuation metrics driven by these figures. Valuecruncher makes our other valuation metrics available for these companies.

To learn more about comparison analysis, please read our guide to comparison analysis

Comments

No comments yet. Login to comment.